Avoid common mistakes on your manuscript.
1 Correction to: Clinical Pharmacokinetics (2021) 60(9):1187–1199 https://doi.org/10.1007/s40262-021-01004-2
In the original online version of the article in Page 1196, para 2, lines 4 to 8 which read as:
The CLR of PDA, HVA and GCDCA-S was 14.8-, 2.3- and 12.5-fold higher than fup times the measured glomerular filtration rate in the absence of probenecid, and 2.4-fold higher (PDA), 30% lower (HVA) and 30% higher (GCDCA-S), after probenecid administration.
Should have read as:
The CLR of PDA, HVA and GCDCA-S was 25.6-, 3.9- and 21.5-fold higher than fup times the measured glomerular filtration rate in the absence of probenecid, and 4.2-fold higher (PDA), 30% higher (HVA) and 2.2-fold higher (GCDCA-S), after probenecid administration.
In the original online version of the article in Page 1196 para 2, lines 17 to 21 which read as:
Finally, for taurine, the CLR was 23-fold and 224-fold lower than the corrected GFR without and with probenecid, respectively, highlighting that renal elimination was likely driven by reabsorption and secretion.
Should have read as:
Finally, for taurine, the CLR was 13.2-fold and 130-fold lower than the corrected GFR without and with probenecid, respectively, highlighting that renal elimination was likely driven by reabsorption and secretion.
In the the Supplementary Information file in section 4 Clinical Study design) lines 9 to 12 which read as:
Their body mass index ranged between 22–28 kg/m2, and their glomerular filtration rate between 3.04–4.59 mL/min/kg (mean = 3.92 mL/min/kg), estimated with the method recommended by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI).
Should have read as:
Their body mass index ranged between 22–28 kg/m2, and their glomerular filtration rate between 1.76–2.65 mL/min/kg (mean = 2.27 mL/min/kg), estimated with the method recommended by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI).
The original article and the online supplementary information file have been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Willemin, ME., Van Der Made, T.K., Pijpers, I. et al. Correction to: Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug–Drug Interactions. Clin Pharmacokinet 61, 463 (2022). https://doi.org/10.1007/s40262-022-01109-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40262-022-01109-2